Organisation paid for research Program year 2025 Source: CMS Open Payments

Johnson County Clinic Trials

Neither a doctor nor a teaching hospital

Research payments

$5,576,414

364 payments

Through program year 2025, Johnson County Clinic Trials is reported as receiving $5,576,414 in research payments, across 364 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$1,353,133	22
2024	Research	$813,948	18
2023	Research	$466,760	11
2022	Research	$837,804	60
2021	Research	$246,261	44
2020	Research	$705,912	90
2019	Research	$1,152,597	119

Breakdown

Who paid Research payments · program years 2019–2025

GlaxoSmithKline, LLC. $4,252,173 354 payments
AstraZeneca Pharmaceuticals LP $1,302,954 9 payments
Alexion Pharmaceuticals, Inc. $21,288 1 payment

Studies the money was for Research payments · program years 2019–2025

A Phase 1/2, First-Time-In Human (Ftih), Randomized, Observer-Blind, P $797,266 37 payments
A Protocol to Collect Human Complement (Either Through Collection of S $680,146 46 payments
RSV Oa=Adj-002 $663,198 103 payments
RSV Mat-001 $499,138 44 payments
A Phase 2a Randomized, Observer-blind, Placebo-controlled, Dosage Optimization, Multi-center Clinical Trial to Evaluate the Safety and Immunogenicity of IVX-A12, a Respiratory Syncytial Virus and Human Metapneumovirus Bivalent Combination Virus-like Particle Protein Subunit Vaccine, in Adults 60 to 85 Years of Age $442,901 2 payments
A Phase 1/2, Randomized, Observer-Blind, Dose-Finding/Dose-Confirmatio $436,923 4 payments
A Phase II Randomised Double blind Placebo controlled Study to Evaluate the Efficacy Safety and Tolerability of AZD6234 in Participants Living with Obesity or Overweight with Comorbidity $408,999 1 payment
Rabies Sam=Cne-001 $264,513 21 payments
Study name not reported $230,157 41 payments
A Phase I/II, Double-blinded, Randomized, Placebo-Controlled, Dose Selection Study in Adults to Assess the Safety and Immunogenicity of AZD4117 and AZD5315 Vaccines PANDA $196,854 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.